Complementary roles of mechanotransduction and inflammation in vascular homeostasis.

artery homeostasis hypertension inflammation mechanotransduction

Journal

Proceedings. Mathematical, physical, and engineering sciences
ISSN: 1364-5021
Titre abrégé: Proc Math Phys Eng Sci
Pays: England
ID NLM: 9891746

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 31 07 2020
accepted: 09 12 2020
entrez: 1 3 2021
pubmed: 2 3 2021
medline: 2 3 2021
Statut: ppublish

Résumé

Arteries are exposed to relentless pulsatile haemodynamic loads, but via mechanical homeostasis they tend to maintain near optimal structure, properties and function over long periods in maturity in health. Numerous insults can compromise such homeostatic tendencies, however, resulting in maladaptations or disease. Chronic inflammation can be counted among the detrimental insults experienced by arteries, yet inflammation can also play important homeostatic roles. In this paper, we present a new theoretical model of complementary mechanobiological and immunobiological control of vascular geometry and composition, and thus properties and function. We motivate and illustrate the model using data for aortic remodelling in a common mouse model of induced hypertension. Predictions match the available data well, noting a need for increased data for further parameter refinement. The overall approach and conclusions are general, however, and help to unify two previously disparate literatures, thus leading to deeper insight into the separate and overlapping roles of mechanobiology and immunobiology in vascular health and disease.

Identifiants

pubmed: 33642928
doi: 10.1098/rspa.2020.0622
pii: rspa20200622
pmc: PMC7897647
doi:

Banques de données

figshare
['10.6084/m9.figshare.c.5253529']

Types de publication

Journal Article

Langues

eng

Pagination

20200622

Subventions

Organisme : NHLBI NIH HHS
ID : P01 HL134605
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL146723
Pays : United States

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

We declare we have no competing interests.

Références

J Vasc Res. 2011;48(3):261-72
pubmed: 21099231
Mol Cell. 2014 Apr 24;54(2):281-8
pubmed: 24766892
Annu Rev Biomed Eng. 2019 Jun 4;21:267-297
pubmed: 31167103
Ann Biomed Eng. 2019 Nov;47(11):2213-2231
pubmed: 31218484
Nature. 2008 Jul 24;454(7203):428-35
pubmed: 18650913
Int J Eng Sci. 2014 Dec 1;85:203-223
pubmed: 25308990
PLoS One. 2014 Dec 11;9(12):e114895
pubmed: 25501574
Cell. 2015 Feb 26;160(5):816-827
pubmed: 25723161
Arterioscler Thromb Vasc Biol. 1999 Aug;19(8):1843-51
pubmed: 10446062
Circ Res. 2015 Jan 16;116(2):312-22
pubmed: 25593276
J Exp Med. 2010 Aug 30;207(9):1951-66
pubmed: 20733031
Hypertension. 2000 Sep;36(3):319-24
pubmed: 10988258
J Hypertens. 2020 Sep;38(9):1682-1698
pubmed: 32649623
Biomech Model Mechanobiol. 2018 Oct;17(5):1451-1470
pubmed: 29968161
Nat Cell Biol. 2001 May;3(5):466-72
pubmed: 11331874
PLoS Comput Biol. 2020 Aug 24;16(8):e1008161
pubmed: 32834001
Circ Res. 1999 Apr 2;84(6):695-703
pubmed: 10189357
Hypertension. 2016 May;67(5):890-896
pubmed: 27001298
Ann Biomed Eng. 2007 Sep;35(9):1498-509
pubmed: 17487585
J Leukoc Biol. 2019 Aug;106(2):283-299
pubmed: 30861205
Am J Pathol. 2000 May;156(5):1489-98
pubmed: 10793060
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1484-9
pubmed: 12552122
J Clin Invest. 2016 Mar 1;126(3):821-8
pubmed: 26928035
J R Soc Interface. 2018 Dec 21;15(149):20180616
pubmed: 30958237
Arteriosclerosis. 1985 Jan-Feb;5(1):19-34
pubmed: 3966906
Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2597-604
pubmed: 17660399
APL Bioeng. 2018 Jun 05;2(2):026108
pubmed: 31069305
Am J Physiol Heart Circ Physiol. 2019 Feb 1;316(2):H265-H278
pubmed: 30412437
J Hypertens. 2020 Jul;38(7):1312-1321
pubmed: 32068640
Hypertension. 2000 Sep;36(3):360-3
pubmed: 10988265
Am J Physiol Heart Circ Physiol. 2015 Sep;309(5):H906-17
pubmed: 26071547
Int J Eng Sci. 2019 Aug;141:35-46
pubmed: 32831391
Br J Pharmacol. 2019 Jun;176(12):1818-1828
pubmed: 29952002
Cell Biochem Biophys. 2008;50(2):53-78
pubmed: 18209957
J Biomech Eng. 2001 Dec;123(6):638-41
pubmed: 11783737
Hypertension. 2011 Feb;57(2):132-40
pubmed: 21149826
J Clin Invest. 1998 Feb 15;101(4):731-6
pubmed: 9466966
J R Soc Interface. 2017 Nov;14(136):
pubmed: 29118111
J Exp Med. 2007 Oct 1;204(10):2449-60
pubmed: 17875676
Biomech Model Mechanobiol. 2018 Oct;17(5):1497-1511
pubmed: 29881909
J Leukoc Biol. 2019 Jul;106(1):119-125
pubmed: 30645000
Hypertension. 2016 Jul;68(1):123-32
pubmed: 27217403
Hypertens Res. 2008 Jun;31(6):1233-40
pubmed: 18716373
J R Soc Interface. 2017 May;14(130):
pubmed: 28566510
Cardiovasc Res. 2008 May 1;78(2):341-8
pubmed: 18299286
J Vasc Res. 1998 Mar-Apr;35(2):93-103
pubmed: 9588872
Circ Res. 2004 May 14;94(9):1203-10
pubmed: 15059935
Nature. 2013 Apr 25;496(7446):445-55
pubmed: 23619691
Clin Sci (Lond). 2007 Jul;113(1):15-23
pubmed: 17536999
J Mech Phys Solids. 2019 Apr;125:298-325
pubmed: 31543547
Hypertension. 2008 Aug;52(2):195-200
pubmed: 18541735
Nat Immunol. 2016 Jan;17(1):9-17
pubmed: 26681457
J Exp Med. 2008 Dec 22;205(13):3159-71
pubmed: 19064699
Circ Res. 1996 Jul;79(1):70-8
pubmed: 8925571
Circ Res. 2014 Feb 14;114(4):616-25
pubmed: 24347665

Auteurs

Marcos Latorre (M)

Department of Biomedical Engineering, Yale University, New Haven, CT, USA.

Bart Spronck (B)

Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
Department of Biomedical Engineering, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.

Jay D Humphrey (JD)

Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.

Classifications MeSH